• Thiothixene: Integrating Efferocytosis Modulation in Psychot

  2026-05-06

  Explore how Thiothixene, a typical antipsychotic agent, uniquely bridges neuropharmacology and immunological efferocytosis enhancement. This article unveils advanced assay design and mechanistic insights that go beyond standard protocols.

• Wnt Agonist 1: Driving Precision in Wnt Pathway Cellular Dif

  2026-05-05

  Wnt agonist 1 (BML-284) enables robust, reproducible activation of canonical Wnt signaling for developmental and cancer biology research. This guide details experimental workflows, troubleshooting strategies, and advanced assay applications, leveraging recent findings on Wnt-driven chemoresistance and translational model optimization.

• Gut Microbiota Dysbiosis Drives α-Synuclein Pathology via C/

  2026-05-05

  This study demonstrates that gut microbiota dysbiosis, induced by the mitochondrial Complex I inhibitor rotenone, is a critical driver of α-synuclein aggregation and dopaminergic neuron loss in a mouse Parkinson’s disease model. The findings link gut-derived inflammation and C/EBPβ/AEP signaling activation to neurodegeneration, highlighting microbiota-targeted interventions as a potential therapeutic avenue.

• D-Luciferin as a Quantitative Bridge: Beyond Tumor Imaging

  2026-05-04

  Explore how D-Luciferin, a premier firefly luciferase substrate, enables quantitative, non-invasive insights into tumor immunology and biomarker validation. This article uniquely connects advanced glioma biomarker research with practical assay strategies for translational bioluminescence imaging.

• Luminescent ATP Detection Assay Kit: Precision in Cellular E

  2026-05-04

  The Luminescent ATP Detection Assay Kit revolutionizes cellular ATP quantification by delivering unmatched sensitivity, rapid workflows, and compatibility with downstream analyses. Its firefly luciferase-based chemistry empowers disease researchers to dissect energy metabolism and stress responses in challenging models, including inflammation and tissue injury.

• HyperFluor 488 Goat Anti-Rabbit IgG: Transforming Fluorescen

  2026-05-03

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody brings next-generation sensitivity and robust signal amplification to immunofluorescence, flow cytometry, and microscopy assays. This article translates recent neuroinflammation research into practical, step-by-step protocols, troubleshooting strategies, and advanced use-cases, revealing how APExBIO’s reagent elevates experimental reliability and clarity.

• MMP7 Drives EMT via E-cadherin/β-Catenin in Biliary Atresia

  2026-05-02

  This study identifies matrix metalloproteinase 7 (MMP7) as a central driver of epithelial–mesenchymal transition (EMT) and liver fibrosis in biliary atresia (BA) by cleaving E-cadherin and activating β-catenin signaling. The findings illuminate a precise mechanistic axis linking MMP7 activity to fibrotic progression and highlight new therapeutic targets for BA treatment.

• Hypothalamic Gene Expression in Caged vs. Cage-Free Laying H

  2026-05-01

  This study applied transcriptomic analysis to reveal how commercial housing systems (caged versus cage-free) affect hypothalamic gene expression in laying hens. The findings highlight substantial molecular differences in stress, metabolism, and hormone-related pathways, offering new perspectives for animal welfare assessment beyond traditional hormone and behavioral metrics.

• Wnt Agonist 1 (BML-284): Advanced Insights for Precision Wnt

  2026-05-01

  Explore the scientific depth of Wnt agonist 1 (BML-284) in canonical Wnt signaling pathway activation, with a focus on its mechanistic action, research applications, and recent breakthroughs in chemoresistance and cellular differentiation studies.

• LG 101506: Redefining RXR Modulation for Translational Immun

  2026-04-30

  This thought-leadership article explores how LG 101506, a synthetic RXR modulator from APExBIO, is catalyzing a new era in translational research. By integrating mechanistic insights into RXR signaling with cutting-edge findings in immune checkpoint regulation, the article provides actionable guidance for researchers seeking to overcome immune resistance and metabolic dysregulation in complex disease models. Drawing on pivotal recent studies in PD-L1 modulation and tumor immunogenicity, it frames a compelling narrative on the strategic deployment of LG 101506 in next-generation research workflows.

• NADH in Mitochondrial Electron Transport Chain Research

  2026-04-30

  Unlock the full potential of NADH as a research-grade coenzyme for mitochondrial electron transport chain studies and advanced disease modeling. This guide details actionable workflows, troubleshooting strategies, and key innovations—empowering scientists to achieve reproducible, high-sensitivity results in redox and metabolic research.

• NLRP10 Drives Keratinocyte Survival and Differentiation in A

  2026-04-29

  This study establishes NLRP10 as a central regulator of epidermal homeostasis by supporting keratinocyte survival and differentiation via p63 stabilization. Reduced NLRP10 expression in atopic dermatitis links genetic risk to impaired skin barrier function, highlighting new directions for targeted interventions.

• Beclin1 Deficiency Reduces DOX-Induced Liver Injury via Ferr

  2026-04-29

  This study elucidates how Beclin1 deficiency mitigates doxorubicin-induced liver injury by suppressing both ferroptosis and autophagy. The findings identify Beclin1 and DHODH as key modulators of hepatic oxidative damage, offering mechanistic insight into potential interventions for chemotherapy-associated hepatotoxicity.

• DMXAA (Vadimezan): Advanced Protocols in Tumor Vascular Disr

  2026-04-28

  DMXAA (Vadimezan) is redefining the landscape of tumor vascular disruption by uniting anti-angiogenic action with immune microenvironment modulation. This guide delivers evidence-driven workflows and troubleshooting strategies for maximizing DMXAA's value in translational cancer biology research.

• Moxidectin Elevates Ergosterol to Synergize Polyenes in Cand

  2026-04-28

  A recent study demonstrates that moxidectin, a macrocyclic lactone anthelmintic, enhances the antifungal efficacy of polyenes against Candida albicans by upregulating ergosterol biosynthesis. This mechanistic insight offers a potential path to more effective oral candidiasis treatments and suggests new research directions for antifungal drug repurposing.

16335 records 1/1089 page Next 12345 下5页 Last page